Amicus Therapeutics Inc (FOLD)
US$ 6.213.85%
Price Chart
Key Statistics
Market Cap
$ 1.91B
P/E Ratio
0.00
Revenue (TTM)
$ 543.14M
Volume
6.65M
52W High
$ 12.65
52W Low
$ 5.82
Dividend Yield
0.00%
Beta
0.64
Technicals
50-Day MA
7.7938
200-Day MA
9.7352
52 Week High
12.65
52 Week Low
5.82
About FOLD
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
Employees
499
Headquarters
Princeton, NJ
CEO
Mr. Bradley L. Campbell M.B.A.
Latest News
Kremlin brings Abkhazia back into fold - Eurasianet
18 hours ago • Google News
2B Residents fold 1,000 paper cranes for cancer awareness - The Berkeley Beacon
8 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg